NAAT (nucleic acid amplification test)
GPTKB entity
Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:molecular_diagnostic_test
|
| gptkbp:advantage |
high sensitivity
high specificity |
| gptkbp:detects |
gptkb:gene
|
| gptkbp:developedBy |
late 20th century
|
| gptkbp:method |
polymerase chain reaction (PCR)
loop-mediated isothermal amplification (LAMP) transcription-mediated amplification (TMA) |
| gptkbp:type |
blood
urine swab sputum |
| gptkbp:usedFor |
diagnosis of infectious diseases
detection of nucleic acids |
| gptkbp:usedIn |
COVID-19 testing
HIV diagnosis tuberculosis diagnosis sexually transmitted infection diagnosis |
| gptkbp:bfsParent |
gptkb:Chlamydia_trachomatis
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
NAAT (nucleic acid amplification test)
|